Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-08-28
2007-08-28
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S357000, C544S360000, C544S379000, C544S377000, C540S575000
Reexamination Certificate
active
10815048
ABSTRACT:
This invention is directed to heterocyclyl-substituted anilino phospholipase C inhibitor compounds useful in treating or ameliorating an inflammatory disorders and/or restenosis of the general formula (I):and enantiomers, diastereomers and pharmaceutically acceptable salts thereof. The present invention is further directed to pharmaceutical compositions comprising the compounds of the present invention and to methods for treating conditions affected by phospholipase modulation.
REFERENCES:
patent: 6906073 (2005-06-01), Du Bois et al.
patent: WO96/10568 (1996-04-01), None
patent: 98/27081 (1998-06-01), None
patent: WO 02/32867 (2002-04-01), None
Chemical Abstract, Database—Chemcats, Catalog Name, Otava Stock Chemicals, Chemical Abstract Service, Columbus, Ohio, Order Nos. 7114960248, 7114960239, 7114960244 and 7114960243, Sep. 24, 2003.
Lagu Bharat
Rupert Kenneth
Wachter Michael
Bernhardt Emily
Dodd Thomas
Janssen Pharmaceutica N.V
LandOfFree
Phospholipase C inhibitors for use in treating inflammatory... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phospholipase C inhibitors for use in treating inflammatory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phospholipase C inhibitors for use in treating inflammatory... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3860032